APO Research
Talk to an analyst

APO RESEARCH · REPORT

Competent Cells

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.

Selected research

Industry Growth & Trends

Global Competent Cells Industry Growth and Trends Forecast to 2032

21 December 2025120 pages

Choose your research edition.

Industry ResearchCompetent Cells Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Competent Cells Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Competent Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Competent Cells Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Competent Cells Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.

According to APO Research, the global Competent Cells market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Competent Cells market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Competent Cells market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Competent Cells market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Competent Cells.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Competent Cells market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Competent Cells Market by Company

Merck KGaA

Thermo Fisher Scientific

Agilent Technologies

Takara Bio

Promega Corporation

Beijing TransGen Biotech

GeneScript Corporation

Yeastern Biotech

New England Biolabs

QIAGEN N.V.

OriGene Technologies

Lucigen

Zymo Research

Bio-Rad Laboratories

Bioline

Delphi Genetics

IBA GmBH

Cell Applications

BioDynamics Laboratory

Scarab Genomics

GCC Biotech

SMOBIO Technology

Edge BioSystems

Competent Cells Segment by Type

Chemically Competent Cells

Electrocompetent Cells

Competent Cells Segment by Application

Subcloning & Routine Cloning

Phage Display Library Construction

Toxic/Unstable DNA Cloning

High-Throughput Cloning

Protein Expression

Mutagenesis

Single-Stranded DNA Production

Bacmid Creation

Cre-Lox Recombination (PIR1/PIR2)

Competent Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Competent Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Competent Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Competent Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Competent Cells companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Competent Cells Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Competent Cells Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Competent Cells Market Share by Region (2021-2026) Table 4. Global Competent Cells Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Competent Cells Market Share by Region (2027-2032) Table 6. Global Competent Cells Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Competent Cells Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Competent Cells Market Size Share by Type (2021-2026) Table 9. Global Competent Cells Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Competent Cells Market Size Share Forecasted by Type (2027-2032) Table 11. North America Competent Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Competent Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Competent Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Competent Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Competent Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Competent Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Competent Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Competent Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Competent Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Competent Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Competent Cells Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Competent Cells Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Competent Cells Market Size Share by Application (2021-2026) Table 24. Global Competent Cells Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Competent Cells Market Size Share Forecasted by Application (2027-2032) Table 26. North America Competent Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Competent Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Competent Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Competent Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Competent Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Competent Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Competent Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Competent Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Competent Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Competent Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Competent Cells Industry Trends Table 37. Competent Cells Industry Drivers Table 38. Competent Cells Industry Opportunities and Challenges Table 39. Competent Cells Industry Restraints Table 40. Global Competent Cells Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Competent Cells Revenue Market Share by Company (2021-2026) Table 42. Global Competent Cells Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Competent Cells Key Company Headquarters & Area Served Table 44. Global Competent Cells Company, Product Type & Application Table 45. Global Competent Cells Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Competent Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Merck KGaA Company Information Table 49. Merck KGaA Business Overview Table 50. Merck KGaA Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Merck KGaA Competent Cells Product Portfolio Table 52. Merck KGaA Recent Development Table 53. Thermo Fisher Scientific Company Information Table 54. Thermo Fisher Scientific Business Overview Table 55. Thermo Fisher Scientific Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Thermo Fisher Scientific Competent Cells Product Portfolio Table 57. Thermo Fisher Scientific Recent Development Table 58. Agilent Technologies Company Information Table 59. Agilent Technologies Business Overview Table 60. Agilent Technologies Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Agilent Technologies Competent Cells Product Portfolio Table 62. Agilent Technologies Recent Development Table 63. Takara Bio Company Information Table 64. Takara Bio Business Overview Table 65. Takara Bio Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Takara Bio Competent Cells Product Portfolio Table 67. Takara Bio Recent Development Table 68. Promega Corporation Company Information Table 69. Promega Corporation Business Overview Table 70. Promega Corporation Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Promega Corporation Competent Cells Product Portfolio Table 72. Promega Corporation Recent Development Table 73. Beijing TransGen Biotech Company Information Table 74. Beijing TransGen Biotech Business Overview Table 75. Beijing TransGen Biotech Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Beijing TransGen Biotech Competent Cells Product Portfolio Table 77. Beijing TransGen Biotech Recent Development Table 78. GeneScript Corporation Company Information Table 79. GeneScript Corporation Business Overview Table 80. GeneScript Corporation Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. GeneScript Corporation Competent Cells Product Portfolio Table 82. GeneScript Corporation Recent Development Table 83. Yeastern Biotech Company Information Table 84. Yeastern Biotech Business Overview Table 85. Yeastern Biotech Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Yeastern Biotech Competent Cells Product Portfolio Table 87. Yeastern Biotech Recent Development Table 88. New England Biolabs Company Information Table 89. New England Biolabs Business Overview Table 90. New England Biolabs Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. New England Biolabs Competent Cells Product Portfolio Table 92. New England Biolabs Recent Development Table 93. QIAGEN N.V. Company Information Table 94. QIAGEN N.V. Business Overview Table 95. QIAGEN N.V. Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. QIAGEN N.V. Competent Cells Product Portfolio Table 97. QIAGEN N.V. Recent Development Table 98. OriGene Technologies Company Information Table 99. OriGene Technologies Business Overview Table 100. OriGene Technologies Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. OriGene Technologies Competent Cells Product Portfolio Table 102. OriGene Technologies Recent Development Table 103. Lucigen Company Information Table 104. Lucigen Business Overview Table 105. Lucigen Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Lucigen Competent Cells Product Portfolio Table 107. Lucigen Recent Development Table 108. Zymo Research Company Information Table 109. Zymo Research Business Overview Table 110. Zymo Research Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Zymo Research Competent Cells Product Portfolio Table 112. Zymo Research Recent Development Table 113. Bio-Rad Laboratories Company Information Table 114. Bio-Rad Laboratories Business Overview Table 115. Bio-Rad Laboratories Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Bio-Rad Laboratories Competent Cells Product Portfolio Table 117. Bio-Rad Laboratories Recent Development Table 118. Bioline Company Information Table 119. Bioline Business Overview Table 120. Bioline Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Bioline Competent Cells Product Portfolio Table 122. Bioline Recent Development Table 123. Delphi Genetics Company Information Table 124. Delphi Genetics Business Overview Table 125. Delphi Genetics Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Delphi Genetics Competent Cells Product Portfolio Table 127. Delphi Genetics Recent Development Table 128. IBA GmBH Company Information Table 129. IBA GmBH Business Overview Table 130. IBA GmBH Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. IBA GmBH Competent Cells Product Portfolio Table 132. IBA GmBH Recent Development Table 133. Cell Applications Company Information Table 134. Cell Applications Business Overview Table 135. Cell Applications Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Cell Applications Competent Cells Product Portfolio Table 137. Cell Applications Recent Development Table 138. BioDynamics Laboratory Company Information Table 139. BioDynamics Laboratory Business Overview Table 140. BioDynamics Laboratory Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. BioDynamics Laboratory Competent Cells Product Portfolio Table 142. BioDynamics Laboratory Recent Development Table 143. Scarab Genomics Company Information Table 144. Scarab Genomics Business Overview Table 145. Scarab Genomics Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Scarab Genomics Competent Cells Product Portfolio Table 147. Scarab Genomics Recent Development Table 148. GCC Biotech Company Information Table 149. GCC Biotech Business Overview Table 150. GCC Biotech Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. GCC Biotech Competent Cells Product Portfolio Table 152. GCC Biotech Recent Development Table 153. SMOBIO Technology Company Information Table 154. SMOBIO Technology Business Overview Table 155. SMOBIO Technology Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. SMOBIO Technology Competent Cells Product Portfolio Table 157. SMOBIO Technology Recent Development Table 158. Edge BioSystems Company Information Table 159. Edge BioSystems Business Overview Table 160. Edge BioSystems Competent Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Edge BioSystems Competent Cells Product Portfolio Table 162. Edge BioSystems Recent Development Table 163. North America Competent Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. North America Competent Cells Market Size by Country (2021-2026) & (US$ Million) Table 165. North America Competent Cells Market Share by Country (2021-2026) Table 166. North America Competent Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. North America Competent Cells Market Share Forecast by Country (2027-2032) Table 168. Europe Competent Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Competent Cells Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Competent Cells Market Share by Country (2021-2026) Table 171. Europe Competent Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Competent Cells Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Competent Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Competent Cells Market Size by Country (2021-2026) & (US$ Million) Table 175. Asia-Pacific Competent Cells Market Share by Country (2021-2026) Table 176. Asia-Pacific Competent Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Asia-Pacific Competent Cells Market Share Forecast by Country (2027-2032) Table 178. Latin America Competent Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America Competent Cells Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America Competent Cells Market Share by Country (2021-2026) Table 181. Latin America Competent Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America Competent Cells Market Share Forecast by Country (2027-2032) Table 183. Middle East & Africa Competent Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East & Africa Competent Cells Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East & Africa Competent Cells Market Share by Country (2021-2026) Table 186. Middle East & Africa Competent Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East & Africa Competent Cells Market Share Forecast by Country (2027-2032) Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Competent Cells Product Image Figure 3. Global Competent Cells Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Competent Cells Market Size (2021-2032) & (US$ Million) Figure 5. Global Competent Cells Market Share by Region: 2025 VS 2032 Figure 6. Global Competent Cells Market Share by Region (2021-2032) Figure 7. North America Competent Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Competent Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Competent Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Competent Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Competent Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Chemically Competent Cells Image Figure 13. Global Chemically Competent Cells Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Electrocompetent Cells Image Figure 15. Global Electrocompetent Cells Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Competent Cells Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Competent Cells Market Share by Type 2025 VS 2032 Figure 18. North America Competent Cells Market Size Share by Type (2021-2032) Figure 19. Europe Competent Cells Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Competent Cells Market Size Share by Type (2021-2032) Figure 21. Latin America Competent Cells Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Competent Cells Market Size Share by Type (2021-2032) Figure 23. Subcloning & Routine Cloning Image Figure 24. Global Subcloning & Routine Cloning Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Phage Display Library Construction Image Figure 26. Global Phage Display Library Construction Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Toxic/Unstable DNA Cloning Image Figure 28. Global Toxic/Unstable DNA Cloning Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. High-Throughput Cloning Image Figure 30. Global High-Throughput Cloning Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Protein Expression Image Figure 32. Global Protein Expression Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Mutagenesis Image Figure 34. Global Mutagenesis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Single-Stranded DNA Production Image Figure 36. Global Single-Stranded DNA Production Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Bacmid Creation Image Figure 38. Global Bacmid Creation Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Cre-Lox Recombination (PIR1/PIR2) Image Figure 40. Global Cre-Lox Recombination (PIR1/PIR2) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Global Competent Cells Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Competent Cells Market Share by Application 2025 VS 2032 Figure 43. North America Competent Cells Market Size Share by Application (2021-2032) Figure 44. Europe Competent Cells Market Size Share by Application (2021-2032) Figure 45. Asia-Pacific Competent Cells Market Size Share by Application (2021-2032) Figure 46. Latin America Competent Cells Market Size Share by Application (2021-2032) Figure 47. Middle East and Africa Competent Cells Market Size Share by Application (2021-2032) Figure 48. Global Top 5 and 10 Competent Cells Players Market Share by Revenue in 2025 Figure 49. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 50. North America Competent Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. North America Competent Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. North America Competent Cells Market Share by Country (2021-2032) Figure 53. Europe Competent Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Competent Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Competent Cells Market Share by Country (2021-2032) Figure 56. Asia-Pacific Competent Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Asia-Pacific Competent Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Asia-Pacific Competent Cells Market Share by Country (2021-2032) Figure 59. Latin America Competent Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Competent Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Competent Cells Market Share by Country (2021-2032) Figure 62. Middle East & Africa Competent Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Middle East & Africa Competent Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 64. Middle East & Africa Competent Cells Market Share by Country (2021-2032) Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Chemically Competent Cells
  • Electrocompetent Cells
Applications
  • Subcloning & Routine Cloning
  • Phage Display Library Construction
  • Toxic/Unstable DNA Cloning
  • High-Throughput Cloning
  • Protein Expression
  • Mutagenesis
  • Single-Stranded DNA Production
  • Bacmid Creation
  • Cre-Lox Recombination (PIR1/PIR2)
Companies covered
  • Merck KGaA
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Takara Bio
  • Promega Corporation
  • Beijing TransGen Biotech
  • GeneScript Corporation
  • Yeastern Biotech
  • New England Biolabs
  • QIAGEN N.V.
  • OriGene Technologies
  • Lucigen
  • Zymo Research
  • Bio-Rad Laboratories
  • Bioline
  • Delphi Genetics
  • IBA GmBH
  • Cell Applications
  • BioDynamics Laboratory
  • Scarab Genomics
  • GCC Biotech
  • SMOBIO Technology
  • Edge BioSystems

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Competent Cells Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Competent Cells Market Size by Region (2021-2032)
  5. 1.4.1 Global Competent Cells Market Size by Region (2021-2026)
  6. 1.4.2 Global Competent Cells Market Size by Region (2027-2032)
  7. 1.5 Key Regions Competent Cells Market Size (2021-2032)
  8. 1.5.1 North America Competent Cells Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Competent Cells Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Competent Cells Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Competent Cells Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Competent Cells Market Size Growth Rate (2021-2032)
2 Competent Cells Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Chemically Competent Cells
  3. 2.1.2 Electrocompetent Cells
  4. 2.2 Global Competent Cells Market Size by Type
  5. 2.2.1 Global Competent Cells Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Competent Cells Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Competent Cells Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Competent Cells Market Size by Regions
  9. 2.3.1 North America Competent Cells Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Competent Cells Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Competent Cells Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Competent Cells Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Competent Cells Market Size Breakdown by Type (2021-2026)
3 Competent Cells Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Subcloning & Routine Cloning
  3. 3.1.2 Phage Display Library Construction
  4. 3.1.3 Toxic/Unstable DNA Cloning
  5. 3.1.4 High-Throughput Cloning
  6. 3.1.5 Protein Expression
  7. 3.1.6 Mutagenesis
  8. 3.1.7 Single-Stranded DNA Production
  9. 3.1.8 Bacmid Creation
  10. 3.1.9 Cre-Lox Recombination (PIR1/PIR2)
  11. 3.2 Global Competent Cells Market Size by Application
  12. 3.2.1 Global Competent Cells Market Size Overview by Application (2021-2032)
  13. 3.2.2 Global Competent Cells Historic Market Size Review by Application (2021-2026)
  14. 3.2.3 Global Competent Cells Market Size Forecasted by Application (2027-2032)
  15. 3.3 Global Competent Cells Market Size by Regions
  16. 3.3.1 North America Competent Cells Market Size Breakdown by Application (2021-2026)
  17. 3.3.2 Europe Competent Cells Market Size Breakdown by Application (2021-2026)
  18. 3.3.3 Asia-Pacific Competent Cells Market Size Breakdown by Application (2021-2026)
  19. 3.3.4 South America Competent Cells Market Size Breakdown by Application (2021-2026)
  20. 3.3.5 Middle East and Africa Competent Cells Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Competent Cells Industry Trends
  2. 4.2 Competent Cells Industry Drivers
  3. 4.3 Competent Cells Industry Opportunities and Challenges
  4. 4.4 Competent Cells Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Competent Cells Revenue (2021-2026)
  2. 5.2 Global Competent Cells Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Competent Cells Key Company Headquarters & Area Served
  4. 5.4 Global Competent Cells Company, Product Type & Application
  5. 5.5 Global Competent Cells Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Competent Cells Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Competent Cells Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Competent Cells Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Merck KGaA
  2. 6.1.1 Merck KGaA Company Information
  3. 6.1.2 Merck KGaA Business Overview
  4. 6.1.3 Merck KGaA Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Merck KGaA Competent Cells Product Portfolio
  6. 6.1.5 Merck KGaA Recent Developments
  7. 6.2 Thermo Fisher Scientific
  8. 6.2.1 Thermo Fisher Scientific Company Information
  9. 6.2.2 Thermo Fisher Scientific Business Overview
  10. 6.2.3 Thermo Fisher Scientific Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Thermo Fisher Scientific Competent Cells Product Portfolio
  12. 6.2.5 Thermo Fisher Scientific Recent Developments
  13. 6.3 Agilent Technologies
  14. 6.3.1 Agilent Technologies Company Information
  15. 6.3.2 Agilent Technologies Business Overview
  16. 6.3.3 Agilent Technologies Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Agilent Technologies Competent Cells Product Portfolio
  18. 6.3.5 Agilent Technologies Recent Developments
  19. 6.4 Takara Bio
  20. 6.4.1 Takara Bio Company Information
  21. 6.4.2 Takara Bio Business Overview
  22. 6.4.3 Takara Bio Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Takara Bio Competent Cells Product Portfolio
  24. 6.4.5 Takara Bio Recent Developments
  25. 6.5 Promega Corporation
  26. 6.5.1 Promega Corporation Company Information
  27. 6.5.2 Promega Corporation Business Overview
  28. 6.5.3 Promega Corporation Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Promega Corporation Competent Cells Product Portfolio
  30. 6.5.5 Promega Corporation Recent Developments
  31. 6.6 Beijing TransGen Biotech
  32. 6.6.1 Beijing TransGen Biotech Company Information
  33. 6.6.2 Beijing TransGen Biotech Business Overview
  34. 6.6.3 Beijing TransGen Biotech Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Beijing TransGen Biotech Competent Cells Product Portfolio
  36. 6.6.5 Beijing TransGen Biotech Recent Developments
  37. 6.7 GeneScript Corporation
  38. 6.7.1 GeneScript Corporation Company Information
  39. 6.7.2 GeneScript Corporation Business Overview
  40. 6.7.3 GeneScript Corporation Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 GeneScript Corporation Competent Cells Product Portfolio
  42. 6.7.5 GeneScript Corporation Recent Developments
  43. 6.8 Yeastern Biotech
  44. 6.8.1 Yeastern Biotech Company Information
  45. 6.8.2 Yeastern Biotech Business Overview
  46. 6.8.3 Yeastern Biotech Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Yeastern Biotech Competent Cells Product Portfolio
  48. 6.8.5 Yeastern Biotech Recent Developments
  49. 6.9 New England Biolabs
  50. 6.9.1 New England Biolabs Company Information
  51. 6.9.2 New England Biolabs Business Overview
  52. 6.9.3 New England Biolabs Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 New England Biolabs Competent Cells Product Portfolio
  54. 6.9.5 New England Biolabs Recent Developments
  55. 6.10 QIAGEN N.V.
  56. 6.10.1 QIAGEN N.V. Company Information
  57. 6.10.2 QIAGEN N.V. Business Overview
  58. 6.10.3 QIAGEN N.V. Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 QIAGEN N.V. Competent Cells Product Portfolio
  60. 6.10.5 QIAGEN N.V. Recent Developments
  61. 6.11 OriGene Technologies
  62. 6.11.1 OriGene Technologies Company Information
  63. 6.11.2 OriGene Technologies Business Overview
  64. 6.11.3 OriGene Technologies Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 OriGene Technologies Competent Cells Product Portfolio
  66. 6.11.5 OriGene Technologies Recent Developments
  67. 6.12 Lucigen
  68. 6.12.1 Lucigen Company Information
  69. 6.12.2 Lucigen Business Overview
  70. 6.12.3 Lucigen Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Lucigen Competent Cells Product Portfolio
  72. 6.12.5 Lucigen Recent Developments
  73. 6.13 Zymo Research
  74. 6.13.1 Zymo Research Company Information
  75. 6.13.2 Zymo Research Business Overview
  76. 6.13.3 Zymo Research Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Zymo Research Competent Cells Product Portfolio
  78. 6.13.5 Zymo Research Recent Developments
  79. 6.14 Bio-Rad Laboratories
  80. 6.14.1 Bio-Rad Laboratories Company Information
  81. 6.14.2 Bio-Rad Laboratories Business Overview
  82. 6.14.3 Bio-Rad Laboratories Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Bio-Rad Laboratories Competent Cells Product Portfolio
  84. 6.14.5 Bio-Rad Laboratories Recent Developments
  85. 6.15 Bioline
  86. 6.15.1 Bioline Company Information
  87. 6.15.2 Bioline Business Overview
  88. 6.15.3 Bioline Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Bioline Competent Cells Product Portfolio
  90. 6.15.5 Bioline Recent Developments
  91. 6.16 Delphi Genetics
  92. 6.16.1 Delphi Genetics Company Information
  93. 6.16.2 Delphi Genetics Business Overview
  94. 6.16.3 Delphi Genetics Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Delphi Genetics Competent Cells Product Portfolio
  96. 6.16.5 Delphi Genetics Recent Developments
  97. 6.17 IBA GmBH
  98. 6.17.1 IBA GmBH Company Information
  99. 6.17.2 IBA GmBH Business Overview
  100. 6.17.3 IBA GmBH Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 IBA GmBH Competent Cells Product Portfolio
  102. 6.17.5 IBA GmBH Recent Developments
  103. 6.18 Cell Applications
  104. 6.18.1 Cell Applications Company Information
  105. 6.18.2 Cell Applications Business Overview
  106. 6.18.3 Cell Applications Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Cell Applications Competent Cells Product Portfolio
  108. 6.18.5 Cell Applications Recent Developments
  109. 6.19 BioDynamics Laboratory
  110. 6.19.1 BioDynamics Laboratory Company Information
  111. 6.19.2 BioDynamics Laboratory Business Overview
  112. 6.19.3 BioDynamics Laboratory Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 BioDynamics Laboratory Competent Cells Product Portfolio
  114. 6.19.5 BioDynamics Laboratory Recent Developments
  115. 6.20 Scarab Genomics
  116. 6.20.1 Scarab Genomics Company Information
  117. 6.20.2 Scarab Genomics Business Overview
  118. 6.20.3 Scarab Genomics Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Scarab Genomics Competent Cells Product Portfolio
  120. 6.20.5 Scarab Genomics Recent Developments
  121. 6.21 GCC Biotech
  122. 6.21.1 GCC Biotech Company Information
  123. 6.21.2 GCC Biotech Business Overview
  124. 6.21.3 GCC Biotech Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 GCC Biotech Competent Cells Product Portfolio
  126. 6.21.5 GCC Biotech Recent Developments
  127. 6.22 SMOBIO Technology
  128. 6.22.1 SMOBIO Technology Company Information
  129. 6.22.2 SMOBIO Technology Business Overview
  130. 6.22.3 SMOBIO Technology Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 SMOBIO Technology Competent Cells Product Portfolio
  132. 6.22.5 SMOBIO Technology Recent Developments
  133. 6.23 Edge BioSystems
  134. 6.23.1 Edge BioSystems Company Information
  135. 6.23.2 Edge BioSystems Business Overview
  136. 6.23.3 Edge BioSystems Competent Cells Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Edge BioSystems Competent Cells Product Portfolio
  138. 6.23.5 Edge BioSystems Recent Developments
7 North America
  1. 7.1 North America Competent Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Competent Cells Market Size by Country (2021-2026)
  3. 7.3 North America Competent Cells Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Competent Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Competent Cells Market Size by Country (2021-2026)
  3. 8.3 Europe Competent Cells Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Competent Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Competent Cells Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Competent Cells Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Competent Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Competent Cells Market Size by Country (2021-2026)
  3. 10.3 South America Competent Cells Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Competent Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Competent Cells Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Competent Cells Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst